Management of cardiovascular diseases in patients with obesity

Carl J Lavie1, Ross Arena2, Martin A Alpert3

  • 1Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, Louisiana 70121, USA.

Insights

Obesity complicates cardiovascular disease (CVD) management and risk. Despite higher CVD incidence, overweight patients show a better prognosis post-event, a phenomenon known as the

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Obesity significantly impacts cardiovascular disease (CVD) risk factors, cardiovascular structure, and function.
  • Overweight and obese individuals exhibit a higher incidence of most CVDs compared to normal-weight individuals.
  • A notable 'obesity paradox' suggests better short- to medium-term prognoses for overweight/obese patients post-CVD events or interventions.

Purpose of the Study:

  • To review the detrimental effects of obesity on coronary heart disease.
  • To examine the limited evidence on weight loss benefits in cardiovascular disease patients.
  • To highlight the need for further research into purposeful weight loss and ideal body composition for CVD management.

Main Methods:

  • Literature review focusing on obesity's impact on cardiovascular diseases.
  • Analysis of existing data on the 'obesity paradox' in cardiovascular outcomes.
  • Synthesis of evidence regarding weight loss efficacy in patients with established CVD.

Main Results:

  • Obesity negatively affects major CVD risk factors and cardiac physiology.
  • Overweight/obese patients demonstrate a survival advantage post-cardiac events or surgery.
  • Data on the benefits of weight reduction for cardiovascular outcomes remain limited.

Conclusions:

  • Understanding the mechanisms behind the obesity paradox is crucial.
  • More research is required to establish the efficacy of intentional weight loss on cardiovascular outcomes.
  • Defining optimal body composition for patients with cardiovascular disease is an unmet need.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
482
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
359
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
314
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
755
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
322